# VE416 for Treatment of Food Allergy

> **NCT03936998** · PHASE1,PHASE2 · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Peanut Allergy

## Interventions

- **COMBINATION_PRODUCT:** Vancomycin plus VE416 before PNOIT
- **COMBINATION_PRODUCT:** Vancomycin plus VE416 with PNOIT
- **COMBINATION_PRODUCT:** Placebo plus VE416 with PNOIT
- **COMBINATION_PRODUCT:** Placebo plus placebo with PNOIT

## Key facts

- **NCT ID:** NCT03936998
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-06-28
- **Primary completion:** 2023-11-01
- **Final completion:** 2024-01-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-10-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03936998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03936998, "VE416 for Treatment of Food Allergy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03936998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*